抗凝剂在支气管小细胞癌治疗中的应用
Anticoagulants in the treatment of small cell carcinoma of the bronchus.
作者信息
Stanford C F
出版信息
Thorax. 1979 Feb;34(1):113-6. doi: 10.1136/thx.34.1.113.
Abstract
The object of this study was to see if the addition of anticoagulants to a regimen of cytotoxic drugs would improve the prognosis in patients with small cell carcinoma of the bronchus. Twenty-four patients were randomly allocated to receive chemotherapy or chemotherapy plus anticoagulants. The median survival in the group receiving the anticoagulants was not improved.
摘要
本研究的目的是观察在细胞毒性药物治疗方案中添加抗凝剂是否会改善支气管小细胞癌患者的预后。24名患者被随机分配接受化疗或化疗加抗凝剂治疗。接受抗凝剂治疗组的中位生存期并未得到改善。
相似文献
1
Anticoagulants in the treatment of small cell carcinoma of the bronchus.抗凝剂在支气管小细胞癌治疗中的应用
Thorax. 1979 Feb;34(1):113-6. doi: 10.1136/thx.34.1.113.
2
[Therapy of inoperable bronchial carcinoma].
Osterr Z Onkol. 1977 Nov 15;4(5-6):106-10.
3
Comparison of vincristine and vindesine in the treatment of inoperable non-small cell bronchial carcinoma.长春新碱与长春地辛治疗无法手术的非小细胞支气管癌的比较。
Cancer Treat Rep. 1983 Dec;67(12):1119-21.
4
Treatment of small-cell carcinoma of bronchus.
Lancet. 1975 Jan 18;1(7899):129-32. doi: 10.1016/s0140-6736(75)91428-2.
5
[Prognostic factors in the chemotherapy of bronchial cancers].[支气管癌化疗中的预后因素]
Schweiz Med Wochenschr. 1974 Feb 23;104(8):268-71.
6
5-year follow-up of cytotoxic chemotherapy as an adjuvant to surgery in carcinoma of the bronchus.细胞毒性化疗作为支气管癌手术辅助治疗的5年随访
Br J Cancer. 1976 Aug;34(2):167-73. doi: 10.1038/bjc.1976.139.
7
[Early results of cytostatic treatment supplementing high-voltage radiotherapy of inoperable small-cell bronchial carcinoma].
Strahlentherapie. 1974 Dec;148(6):560-3.
8
Small cell carcinoma: combined approach to treatment.小细胞癌：综合治疗方法。
Thorax. 1979 Dec;34(6):789-93. doi: 10.1136/thx.34.6.789.
9
[Chemotherapy of inoperable bronchopulmonary carcinoma].[不可切除支气管肺癌的化疗]
Minerva Chir. 1973 Mar 15;28(5):367-77.
10
[Chemotherapy of bronchial carcinomas].[支气管癌的化疗]
Med Welt. 1982 Mar 5;33(9):314-7.
引用本文的文献
1
Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation.癌症患者在无抗凝治疗或预防指征的情况下使用口服抗凝药物。
Cochrane Database Syst Rev. 2021 Oct 8;10(10):CD006466. doi: 10.1002/14651858.CD006466.pub7.
2
Natural Coumarins: Exploring the Pharmacological Complexity and Underlying Molecular Mechanisms.天然香豆素：探索药理学复杂性及潜在分子机制。
Oxid Med Cell Longev. 2021 Aug 23;2021:6492346. doi: 10.1155/2021/6492346. eCollection 2021.
3
American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer.美国血液学会 2021 年静脉血栓栓塞症管理指南：癌症患者的预防和治疗。
Blood Adv. 2021 Feb 23;5(4):927-974. doi: 10.1182/bloodadvances.2020003442.
4
Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation.在无抗凝治疗或预防指征的癌症患者中进行口服抗凝治疗。
Cochrane Database Syst Rev. 2017 Dec 29;12(12):CD006466. doi: 10.1002/14651858.CD006466.pub6.
5
Parenteral anticoagulation in ambulatory patients with cancer.癌症门诊患者的胃肠外抗凝治疗
Cochrane Database Syst Rev. 2017 Sep 11;9(9):CD006652. doi: 10.1002/14651858.CD006652.pub5.
6
Rectal bleeding and previous anticoagulant treatment in patients with colorectal cancer do not predict outcome.结直肠癌患者的直肠出血和既往抗凝治疗不能预测预后。
Tech Coloproctol. 2007 Jun;11(2):121-6; discussion 126-7. doi: 10.1007/s10151-007-0341-2. Epub 2007 May 25.
7
Coupling of proadipocyte growth arrest and differentiation. I. Induction by heparinized medium containing human plasma.前脂肪细胞生长停滞与分化的偶联。I. 含人血浆的肝素化培养基的诱导作用。
J Cell Biol. 1982 Aug;94(2):394-9. doi: 10.1083/jcb.94.2.394.
8
Abnormal haemostasis in small cell lung cancer.小细胞肺癌中的异常止血
Thorax. 1988 Dec;43(12):978-81. doi: 10.1136/thx.43.12.978.
本文引用的文献
1
Fibrin in human tumors.人类肿瘤中的纤维蛋白。
Cancer Res. 1960 Jun;20:592-3.
2
CELL TYPE AND THE NATURAL HISTORY OF LUNG CANCER.细胞类型与肺癌的自然史
JAMA. 1965 Jul 5;193:52-4. doi: 10.1001/jama.1965.03090010058016.
3
Pathogenesis of metastasis formation observed in vivo in the rabbit ear chamber.在兔耳室体内观察到的转移形成的发病机制。
AMA Arch Pathol. 1958 Oct;66(4):550-68.
4
Coagulation disorders in cancer. I. Clinical and laboratory studies.癌症中的凝血障碍。I. 临床与实验室研究。
Cancer. 1967 Sep;20(9):1452-65. doi: 10.1002/1097-0142(196709)20:9<1452::aid-cncr2820200912>3.0.co;2-t.
5
Alkylating agents in bronchogenic carcinoma.支气管源性癌中的烷化剂。
Am J Med. 1969 Apr;46(4):516-25. doi: 10.1016/0002-9343(69)90071-0.
6
7
Inhibitive effect of heparin and dextran sulfate on experimental pulmonary metastases.
Gan. 1970 Apr;61(2):125-30.
8
Tumour growth and spontaneous metastasis spread in two syngeneic systems.肿瘤在两个同基因系统中的生长和自发转移扩散。
Acta Pathol Microbiol Scand A. 1970;78(2):131-42. doi: 10.1111/j.1699-0463.1970.tb00248.x.
9
Proceedings: Small cell carcinoma of the lung: staging, paraneoplastic syndromes, treatment, and survival.
Cancer. 1974 Feb;33(2):527-32. doi: 10.1002/1097-0142(197402)33:2<527::aid-cncr2820330230>3.0.co;2-r.
10
Use of BCG as an immunostimulant in the surgical treatment of carcinoma of the lung.卡介苗作为免疫刺激剂在肺癌手术治疗中的应用。
Thorax. 1974 Nov;29(6):654-8. doi: 10.1136/thx.29.6.654.
Zotero 插件